微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 95.71% | 13.86% | 16.47% | 1/55 | 56.48% | 荣昌生物 | 95.71% | 行业排名> |
| 2026-03-31 | 82.18% | -1.3% | -5.85% | 11/55 | 60.48% | 我武生物 | 95.25% | 行业排名> |
| 2025-12-31 | 87.28% | 8.61% | 3.58% | 11/55 | 65.25% | 我武生物 | 95.24% | 行业排名> |
| 2025-09-30 | 84.27% | 5.66% | 0.25% | 10/55 | 66.5% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 84.06% | 7.4% | 0.96% | 11/55 | 67.83% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 83.26% | 7.44% | 3.61% | 13/55 | 36.56% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 80.36% | 3.78% | 0.76% | 16/55 | 67.21% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 79.75% | 3.72% | 1.9% | 17/55 | 69.22% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 78.27% | 1.1% | 1% | 16/55 | 68.29% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 77.5% | -8.91% | 0.08% | 21/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 77.43% | 19.56% | 0.7% | 22/55 | 67.71% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 76.89% | 26.57% | -0.68% | 24/55 | 67.65% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 77.42% | 48.85% | -9% | 22/55 | 62.76% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 85.08% | 142.71% | 31.36% | 15/55 | 69.01% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 64.77% | -31.95% | 6.61% | 32/55 | 67.1% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 60.75% | -33.27% | 16.8% | 35/55 | 70.88% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 52.01% | -35.64% | 48.38% | 37/55 | 68.78% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 35.05% | 2% | -63.17% | 37/55 | 71.21% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 95.18% | 292.89% | 4.54% | 3/55 | 71.82% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 91.04% | 2% | 12.66% | 7/55 | 73.6% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 80.81% | 2% | 233.6% | 26/55 | 73.47% | 百奥泰 | 96.33% | 行业排名> |
| 2020-12-31 | 24.22% | 2% | 2% | 44/55 | 71.4% | 义翘神州 | 96.83% | 行业排名> |